Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Scientific Reports|November 3, 2021
Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphomaErkuden Casales, Eva Martisova, Helena Villanueva, et al.
Cancer Treatment and Research Communications|January 31, 2026
Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancerJesus Edgardo Hernandez-Hernandez, César Octavio Lara-Torres, Alejandro Aranda-Gutierrez, et al.
Viruses|November 27, 2025
Antiviral Activity of Essential Oils Against Avian Influenza Virus H7N3 In Vitro and In Ovo ModelsInkar Castellanos-Huerta, Jaime A Ángel-Isaza, Lucio Bacab-Cab, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 22, 2025
Support and care needs among Mexican women with metastatic breast cancerCynthia Villarreal-Garza, Alejandro Aranda-Gutierrez, Ana S Ferrigno Guajardo, et al.
Sexual Health|November 24, 2025
Cancer screening guidelines for transgender individuals: a narrative review of current recommendations and practice gapsAlejandro Aranda-Gutierrez, Ilana de la Puente Tawil, José Manuel Moreno Mirón, et al.
Cellular and Molecular Life Sciences : CMLS|April 28, 2016
Capsid-deficient alphaviruses generate propagative infectious microvesicles at the plasma membraneMarta Ruiz-Guillen, Evgeni Gabev, Jose I Quetglas, et al.
The Lancet. Oncology|May 31, 2025
National cancer control plans in Latin America and the Caribbean: challenges and future directionsCynthia Villarreal-Garza, Alejandro Aranda-Gutierrez, David G Gonzalez-Sanchez, et al.
Frontiers in Oncology|June 15, 2026
Trop-2 expression is associated with poor survival in pleural mesotheliomaAlejandro Aviles-Salas, Norma Hernández-Pedro, Enrique Caballé-Perez, et al.
Cancer Research Communications|July 25, 2022
Influence of germline BRCA genotype on the survival of patients with triple-negative breast cancerCynthia Villarreal-Garza, Ana S Ferrigno, Alejandro Aranda-Gutierrez, et al.
JCO Global Oncology|March 19, 2026
Preferences in Cyclin-Dependent Kinase 4/6 Inhibitors for Advanced Breast Cancer Among Medical Oncologists in Latin AmericaCynthia Villarreal-Garza, Andres Meraz-Brenez, Agatha Reyes Morales, et al.
Pageof 4